FICKENSCHER JAMES E (Chief Financial Officer) received a stock award from ZYNERBA PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/11/2023ACC: 0001140361-23-047742
Officer· Chief Financial Officer
Since Aug 2018
-503.09K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
170K acquired · 673.09K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−123.09K
Price / share
—
Trade value
—
% of position
32.6%
10/10/2023
378.09K→255K
Common Stock
Direct
Shares
+170K
Price / share
—
Trade value
—
% of position
66.7%
10/10/2023
255K→425K
Common Stock
Direct
Shares
−425K
Price / share
—
Trade value
—
% of position
New position
10/10/2023
425K→0.00
Total
Net shares
−378.09K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/10/2023 | U · U | −123.09K | — | — | 32.6% | 378.09K | 255K |
| Common Stock Direct | 10/10/2023 | A · Award | +170K | — | — | 66.7% | 255K | 425K |
| Common Stock Direct | 10/10/2023 | U · U | −425K | — | — | New position | 425K | 0.00 |
| Total | −378.09K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
125K shares
Shares
−125K
Strike price
2.41
Held after
0.00
Exercisable
—
10/10/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock125K shares | 10/10/2023 | D · Disposition | −125K | 2.41 | — | 0.00 |